phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

In the 2020 election, Americans nationwide cast their ballots with two major issues on their minds – the economy and coronavirus. Health care specific concerns centered on pre-existing conditions protections and rising out-of-pocket costs exacerbated by declining coverage. But how do these trends compare at the state level?

PhRMA_Catalyst_PollingBlog_Graph2_12_14_2020

Our post-election data show that surveyed voters in 12 key states mirror this national sentiment. Here are three key examples:

  1. The economy and the COVID-19 pandemic are the two most important issues to voters.

    Across the 12 states we surveyed, COVID-19 and the economy were cited as the top two most important issues to voters. For example, one-third of Pennsylvania voters said that the economy was the most important issue, with 30% of Georgians echoing the same sentiment. Meanwhile, voters in Florida (31%), North Carolina (31%), Arizona (30%) and Michigan (30%) prioritized the pandemic. Conversely, prescription drug costs was not a top voting issue, with only 0-1% of voters in the states we surveyed putting it among their top two.

    PhRMA_Catalyst_PollingBlog_12-15-2020_Graph1
  2. In addition to COVID-19, the cost of health insurance premiums, protections for pre-existing conditions and out-of-pocket costs are the most important health care issues.

    Beside the pandemic, voters overwhelmingly said the cost of health insurance was the top health care issue. Further analysis of the data helps explain why voters are worried about their ability to afford and access care when they need it. At least two in five voters across all polled states said they are paying more out of pocket now to cover health expenses than they did four years ago. That problem is more acute in states like Florida (45%), Georgia (45%) and Minnesota (46%), where almost half of all voters reported they are now paying more out of pocket than they were just a few years ago.

    PhRMA_Catalyst_PollingBlog_12-15-2020_Graph2
  3. Out-of-pocket costs are a barrier to affording health care.

    Voters across all of the states we surveyed consistently identified out-of-pocket costs, cost of insurance premiums and cost of insurance deductibles as a barrier to affording the health care they need. Over the past decade, deductibles have grown both in prevalence and size; the share of the adult population in private health plans with deductibles of $1,000 or more doubled between 2010 and 2020. It should be no surprise, then, that voters consider it a top priority for policymakers to focus on making insurance more affordable.


    PhRMA_Catalyst_PollingBlog_12-15-2020_Graph3

Overall, these results further demonstrate a continued need to work toward ensuring Americans can access and afford needed treatment and care, while addressing major health concerns like the COVID-19 pandemic. Biopharmaceutical companies are working around the clock with one shared goal: beat COVID-19. At the same time, our industry is actively advocating for solutions — ensuring patients benefit from rebates at the pharmacy counter, covering medicines from day one, lowering cost sharing and making coupons count — that address the most pressing concerns for Americans nationwide.

Nick McGee

Nick McGee is deputy vice president, public affairs, at PhRMA focusing on communications strategies and activities for the organization’s advocacy priorities.

Nick McGee

Survey confirms too many insured Americans face barriers to reliable health care

April 22, 2026

Insurers routinely block seniors’ access to medicines in Medicare Part D

March 18, 2026

Americans believe U.S. pharma leadership needs to be protected

February 26, 2026

50-state poll says Americans are concerned that hospital markups hurt patients

January 27, 2026

Election insights: Voter priorities in the states

Health Insurance

Out-of-Pocket Costs

Coronavirus

Polling

Election insights: Voter priorities in the states

December 17, 2020

Election insights: Voter priorities in the states

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list